NEW YORK (GenomeWeb News) – The Two Blades Foundation today said it has completed a non-exclusive licensing agreement with KWS SAAT covering Two Blades' Transcription Activator Like effector code technology for genome engineering in certain crops.

The technology is for making specific changes in genomes based on novel sequence-specific DNA-binding proteins. TAL effector proteins can be designed to recognize almost any DNA sequence of interest and specific locations in the genome can be targeted for gene replacement and gene function modulation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.